Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.320
+0.130 (10.92%)
At close: May 12, 2025, 4:00 PM
1.330
+0.010 (0.76%)
After-hours: May 12, 2025, 7:58 PM EDT
Humacyte Employees
As of December 31, 2024, Humacyte had 220 total employees, including 218 full-time and 2 part-time employees. The number of employees increased by 35 or 18.92% compared to the previous year.
Employees
220
Change (1Y)
35
Growth (1Y)
18.92%
Revenue / Employee
n/a
Profits / Employee
-$675,914
Market Cap
204.76M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 220 | 35 | 18.92% |
| Dec 31, 2023 | 185 | 21 | 12.80% |
| Dec 31, 2022 | 164 | 18 | 12.33% |
| Dec 31, 2021 | 146 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HUMA News
- 3 days ago - Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025 - GlobeNewsWire
- 6 weeks ago - Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 6 weeks ago - Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025 - GlobeNewsWire
- 6 weeks ago - Humacyte, Inc. Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 6 weeks ago - Humacyte, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics - GlobeNewsWire
- 2 months ago - Trestle Bio Announces Research Collaboration with Humacyte - Business Wire